CCNA2 and hepatocellular carcinoma: In particular, OXPHOS was shown to be among the most significantly downregulated pathways in a homogeneous HCC subgroup driven by the activation of cyclin A2 (CCNA2) or cyclin E1 (CCNE1) gene [38].